Literature DB >> 10845231

Hemophagocytosis complicating Kawasaki disease.

W al-Eid1, A al-Jefri, S Bahabri, S al-Mayouf.   

Abstract

A 6-year-old boy developed hemophagocytic syndrome during the recurrent course of Kawasaki disease. Despite the appropriate treatment modalities for Kawasaki disease, he developed pancytopenia, marked hepatosplenomegaly, high-grade fever, hyperferritinemia, hypertriglyceremia, and evidence of hemophagocytosis in the liver biopsy. Although the course was stormy, he responded well to a combination therapy of corticosteroids, etoposide VP16, and granulocyte colony-stimulating factor G-CSF. The clinical course and the treatment given were compared with the previous reported cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845231     DOI: 10.1080/088800100276316

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  10 in total

1.  Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl.

Authors:  Vehbi Doğan; Erhan Karaaslan; Samet Özer; Rüveyda Gümüşer; Resul Yılmaz
Journal:  Balkan Med J       Date:  2016-07-01       Impact factor: 2.021

2.  Very high serum ferritin levels in three newborns with Kawasaki-like illness.

Authors:  Arwa Nasir; Hosam Al Tatari; Mohamed A Hamdan
Journal:  Paediatr Child Health       Date:  2012-04       Impact factor: 2.253

3.  Non-Langerhans cell histiocytosis in a child with Kawasaki disease.

Authors:  Ho-Chang Kuo; Chih-Chiang Wu; Tsung-Hsien Yang; Hong-Ren Yu; Chi-Di Liang; Yi-Ju Chen; Kuender D Yang
Journal:  BMJ Case Rep       Date:  2009-04-28

Review 4.  MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.

Authors:  Salika Gadiwala; Ayushi Mistry; Sejal Patel; Avanthika Chaithanya; Stuti Pathak; Travis Satnarine; Daria Bekina-Sreenivasan; Abdul Akim Bakarr; Bibhuti Bhusan Das; Raja Chandra Chakinala; Saurabhkumar Patel; Sathya Areti
Journal:  Infez Med       Date:  2022-09-01

5.  Clinical characteristics of hemophagocytic lymphohistiocytosis following Kawasaki disease: differentiation from recurrent Kawasaki disease.

Authors:  Hae-Ryong Kang; Yong-Hoon Kwon; Eun-Sun Yoo; Kyung-Ha Ryu; Ji Yoon Kim; Heung-Sik Kim; Hwang Min Kim; Young-Ho Lee
Journal:  Blood Res       Date:  2013-12-24

6.  The use of corticosteroid therapy in refractory Kawasaki patients.

Authors:  Sulaiman M Al-Mayouf
Journal:  Clin Rheumatol       Date:  2003-12-16       Impact factor: 2.980

7.  Differentiation between incomplete Kawasaki disease and secondary hemophagocytic lymphohistiocytosis following Kawasaki disease using N-terminal pro-brain natriuretic peptide.

Authors:  Jung Eun Choi; Yujin Kwak; Jung Won Huh; Eun-Sun Yoo; Kyung-Ha Ryu; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2018-05-28

8.  Kawasaki Disease Complicated With Macrophage Activation Syndrome: Case Reports and Literature Review.

Authors:  Ping Jin; Yong Luo; Xi Liu; Jinji Xu; Chunyi Liu
Journal:  Front Pediatr       Date:  2019-11-01       Impact factor: 3.418

Review 9.  Understanding organ dysfunction in hemophagocytic lymphohistiocytosis.

Authors:  Caroline Créput; Lionel Galicier; Sophie Buyse; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-04-22       Impact factor: 41.787

10.  Imaging characteristics of hemophagocytic lymphohistiocytosis.

Authors:  Nancy E Fitzgerald; Kenneth L MacClain
Journal:  Pediatr Radiol       Date:  2003-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.